← Leaderboards
Taben M. Hale
University Of Arizona
$2,333,273
Attributed
$2,333,273
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $599.5K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,333,273 · 2
By mechanism
R01$1,939,780 · 1
R56$393,493 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- W Daniel Stamer$14,957,526
- Ruslan Rafikov$8,067,608
- Zhiyu Dai$7,862,593
- Maria Elena Martinez$16,585,287
- Jeannie Kim Lee$3,070,501
Others in their field
Other Emerging Leaders on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Michael P Harms · Washington University$13,645,932
- Xinhua Li · Nano Terra, Inc.$11,941,250
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,324,161
- Katherine Teresa Mills · Tulane University Of Louisiana$11,000,903
- Colin Masters · University Of Melbourne$10,651,748
Research focus
HypertensionMissionGenesHeart FailureInterdisciplinary ApproachMethodologyFibroblastsGene ExpressionHeart DiseasesEnsureAmericanInjuredIn VitroIn VivoAffectCardiacFibrosisFutureCicatrixHeartCause Of DeathCoronary FibrosisCellsNational Heart, Lung, And Blood Institute
Grant awards (5)
Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis$382,402
R01 · FY2025 · HL · contact PI
Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis$361,606
R01 · FY2024 · HL · contact PI
Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis$596,239
R01 · FY2023 · HL · contact PI
Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis$599,533
R01 · FY2022 · HL · contact PI
Identifying a Pathogenic Fibroblast Subpopulation to Target for Protection Against Cardiac Fibrosis$393,493
R56 · FY2018 · HL · contact PI